Jorge DiMartino

Direktor/Vorstandsmitglied bei Gotham Therapeutics Corp.

Vermögen: 308 941 $ am 30.04.2024

60 Jahre

Health Technology

Consumer Services

Aktive Positionen von Jorge DiMartino

Unternehmen	Position	Beginn	Ende
Gotham Therapeutics Corp. Gotham Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Gotham Therapeutics Corp. develops and manufactures pharmaceutical medicines. The firm develops new treatment options for patients suffering from cancers, auto-immune and neurodegenerative diseases. The company was founded by Samie Jaffrey in 2017 and is headquartered in New York, NY.	Direktor/Vorstandsmitglied	-	-

Unternehmen	Position	Beginn	Ende
KRONOS BIO, INC.	Technik-/Wissenschafts-/F&E-Leiter	01.12.2019	16.02.2024
CELGENE	Corporate Officer/Principal	01.04.2011	01.12.2019
Genentech, Inc. Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.	Technik-/Wissenschafts-/F&E-Leiter	-	-

University of California San Diego	Doctorate Degree
Cornell University Graduate School	Doctorate Degree

International

Vereinigte Staaten

Operativ

Sektoral

Health Technology	5
Consumer Services	3

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	1
KRONOS BIO, INC.	Health Technology

Private Unternehmen	3
Celgene Corp. Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ.	Health Technology
Genentech, Inc. Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.	Health Technology
Gotham Therapeutics Corp. Gotham Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Gotham Therapeutics Corp. develops and manufactures pharmaceutical medicines. The firm develops new treatment options for patients suffering from cancers, auto-immune and neurodegenerative diseases. The company was founded by Samie Jaffrey in 2017 and is headquartered in New York, NY.	Health Technology